Page last updated: 2024-08-16

technetium tc 99m sestamibi and Lewy Body Disease

technetium tc 99m sestamibi has been researched along with Lewy Body Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inui, Y; Iwata, N; Katada, K; Kosaka, K; Manabe, Y; Sarai, M; Sato, T; Toyama, H1

Other Studies

1 other study(ies) available for technetium tc 99m sestamibi and Lewy Body Disease

ArticleYear
Evaluation of probable or possible dementia with lewy bodies using 123I-IMP brain perfusion SPECT, 123I-MIBG, and 99mTc-MIBI myocardial SPECT.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:10

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Brain; Female; Heart; Humans; Imaging, Three-Dimensional; Iofetamine; Lewy Body Disease; Male; Perfusion; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon

2007